Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Fennec Pharmaceuticals Inc       CA31447P1009

 SummaryChartsNewsCalendarCompanyFinancialsConsensus 
Financials ($)
More Financials
Company
Fennec Pharmaceuticals, Inc. operates as a small stage biotechnology company.It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham,... 
Sector
Biotechnology & Medical Research
Calendar
10/14 | 11:30pmPresentation
More about the company
Latest news on FENNEC PHARMACEUTICALS INC
09/14 FENNEC PHARMACEUTICALS INC. (OTCMKTS : FENCF) Files An 8-K Financial Statements ..
09/13 FENNEC PHARMACEUTICALS : IIROC Trade Resumption - FRX
09/13 FENNER : IIROC Trade Resumption - Fennec Pharmaceuticals Inc.
09/13 FENNER : IIROC Trade Halt - Fennec Pharmaceuticals Inc.
09/13 FENNEC PHARMACEUTICALS : IIROC Trading Halt - FRX
08/14 FENNEC PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condi..
08/11 FENNEC PHARMACEUTICALS : Provides Corporate Update and Announces Second Quarter ..
06/29 FENNEC PHARMACEUTICALS INC. : Submission of Matters to a Vote of Security Holder..
06/28 FENNEC PHARMACEUTICALS : Announces Results of Annual Meeting
06/09 FENNEC PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Unregi..
More news
Sector news : Bio Therapeutic Drugs
09/20DJSANOFI : Alnylam Report Positive Patisiran Phase III Trial, First-Ever for RNAi ..
09/15 Drug industry on tenterhooks as Maryland price-gouging law nears
09/07 New AstraZeneca, Amgen drug looks strong rival in severe asthma
08/30DJFDA Approves Pioneering Cancer Treatment With $475,000 Price Tag -- Update
08/30DJFDA Approves Pioneering Cancer Treatment With $475,000 Price Tag
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
09/13 Fennec Pharma uplisted to Nasdaq Capital Market today
08/17 Fennec Pharmaceuticals (FENCF) Presents At Wedbush PacGrow Healthcare Confere..
08/11 Fennec Pharmaceuticals reports Q2 results
06/09 Fennec Pharma completes private $7.6M capital raise
05/18 Premarket analyst action - healthcare
Chart FENNEC PHARMACEUTICALS INC
Duration : Period :
Fennec Pharmaceuticals Inc Technical Analysis Chart | CA31447P1009 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target -100%
Managers
NameTitle
Rostislav C. Raykov Chief Executive Officer & Director
Khalid Islam Chairman
Robert C. Andrade Chief Financial Officer
Chris A. Rallis Independent Director
Adrian J. Haigh Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
FENNEC PHARMACEUTICALS INC313.84%130
AMGEN28.70%135 544
CELGENE CORPORATION24.61%112 572
GILEAD SCIENCES15.40%108 744
REGENERON PHARMACEUTICALS19.36%46 367
VERTEX PHARMACEUTICALS107.30%38 136